| Anna Johansen-ccc/slp | |
|
47760 Sunset Dr, Becida, MN 56678-4493 | |
| (218) 854-7334 | |
| Not Available |
| Full Name | Anna Johansen-ccc/slp |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 47760 Sunset Dr, Becida, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891952644 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 250269 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Anna Johansen-ccc/slp 47760 Sunset Dr, Becida, MN 56678-4493 Ph: (218) 854-7334 | Anna Johansen-ccc/slp 47760 Sunset Dr, Becida, MN 56678-4493 Ph: (218) 854-7334 |
News Archive
A new discovery may explain why a tuberculosis vaccine is not as effective for some people as anticipated, and potentially explains why other vaccines do not work as well for some as they do for others.
Littleton-based Alcohol Monitoring Systems, Inc. (AMS), the world's largest provider of high-tech alcohol monitoring technologies, has been awarded ISO 9001: 2008 certification by TUV Rheinland of North America, based on the standards established by the International Organizations of Standardization (ISO).
Carbon dioxide emission reductions required to limit global warming to 2-C are becoming a receding goal based on new figures reported today in the latest Global Carbon Project (GCP) calculations published today in the advanced online edition of Nature Climate Change. "A shift to a 2-C pathway requires an immediate, large, and sustained global mitigation effort" says GCP executive-director and CSIRO co-author of the paper, Dr Pep Canadell.
Rep. Henry Waxman and Sen. Jay Rockefeller have introduced legislation that would extend Medicaid rebates to "dual eligibles" and those who qualify for the low-income subsidy program — a plan they say could reduce the deficit by $112 billion over the next ten years.
Researchers at the Buck Institute for Age Research have successfully used human induced pluripotent stem cells (iPSCs) to treat rodents afflicted with Parkinson's Disease (PD). The research, which validates a scalable protocol that the same group had previously developed, can be used to manufacture the type of neurons needed to treat the disease and paves the way for the use of iPSC's in various biomedical applications. Results of the research, from the laboratory of Buck faculty Xianmin Zeng, Ph.D., are published August 16, 2010 in the on-line edition of the journal Stem Cells.
› Verified 2 days ago
Anna Lee Johansen, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 47760 Sunset Dr, Becida, MN 56678 Phone: 218-854-7334 |